  This work aims to investigate the accuracy of quantitative SPECT imaging of
$^{177}$Lu in the presence of $^{90}$Y, which occurs in dual-isotope
radiopharmaceutical therapy (RPT) involving both isotopes. We used the GATE
Monte Carlo simulation toolkit to conduct a phantom study, simulating spheres
filled with $^{177}$Lu and $^{90}$Y placed in a cylindrical water phantom that
was also filled with activity of both radionuclides. We simulated multiple
phantom configurations and activity combinations by varying the location of the
spheres, the concentrations of $^{177}$Lu and $^{90}$Y in the spheres, and the
amount of background activity. We investigated two different scatter window
widths to be used with triple energy window (TEW) scatter correction. We also
created multiple realizations of each configuration to improve our assessment,
leading to a total of 540 simulations. Each configuration was imaged using a
simulated Siemens SPECT camera. The projections were reconstructed using the
standard 3D OSEM algorithm, and errors associated with $^{177}$Lu activity
quantification and contrast-to-noise ratios (CNRs) were determined. In all
configurations, the quantification error was within $\pm$6% of the no-$^{90}$Y
case, and we found that quantitative accuracy may slightly improve when
$^{90}$Y is present because of reduction of errors associated with TEW scatter
correction. The CNRs were not significantly impacted by the presence of
$^{90}$Y, but they were increased when a wider scatter window width was used
for TEW scatter correction. The width of the scatter windows made a small but
statistically significant difference of 1-2% on the recovered $^{177}$Lu
activity. Based on these results, we can conclude that activity quantification
of $^{177}$Lu and lesion detectability is not degraded by the presence of
$^{90}$Y.
